Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents

NCT02337127 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Lamivudine

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital